1. Catalog
  2. Eyes on GLP-1: Impact on Ocular Health | Recording
Eyes on GLP-1: Impact on Ocular Health | Recording

ADA Member Exclusive Recorded Webinar

Join American Diabetes Association® (ADA) professional members for Eyes on GLP‑1: Impact on Ocular Health, a focused, one‑hour live discussion exploring how GLP‑1 receptor agonists may influence ocular health. This session will review current evidence linking GLP‑1 therapy to various ocular outcomes and outline key monitoring and counseling considerations for patients using these therapies, concluding with practical insights and an interactive Q&A.
Overview

Join American Diabetes Association® (ADA) professional members for Eyes on GLP‑1: Impact on Ocular Health, a focused, one‑hour live discussion exploring how GLP‑1 receptor agonists may influence ocular health. This session will review current evidence linking GLP‑1 therapy to various ocular outcomes and outline key monitoring and counseling considerations for patients using these therapies, concluding with practical insights and an interactive Q&A.

Hosted by the Eye Health Interest Group Leadership Team

Learning Objectives
  • Describe how GLP-1 receptor agonists may affect ocular health.
  • Review evidence linking GLP-1 therapy to ocular outcomes.
  • Identify monitoring and counseling considerations for patients on GLP-1 therapy.
Speakers
Brian VanderBeek, MD, MPH, MSCE
Associate Professor of Ophthalmology at the Hospital of the University of Pennsylvania
Moderator
Andrew J. Barkmeier, M.D.
Ophthalmologist, Mayo Clinic
Summary
Availability:
On-Demand
Expires on Mar 25, 2028
Cost:
FREE
Credit Offered:
No Credit Offered
Create Account
Android App Download IOS App Download Powered By